Health economics in haemophilia: a review from the clinician's perspective.

Escobar, M A

Escobar, M A.

Affiliation

Escobar MA; Gulf States Hemophilia and Thrombophilia Center, University of Texas Health Science Center, Houston, TX, USA. miguel.escobar@uth.tmc.edu

Haemophilia ; 16 Suppl 3: 29-34, 2010 May.

Article in En | MEDLINE | ID: mdl-20586799

Subject(s)

Factor VIIa/economics; Hemophilia A/economics; Hemophilia B/economics; Quality of Life; Quality-Adjusted Life Years; Cost-Benefit Analysis; Factor VIIa/therapeutic use; Health Care Costs; Hemophilia A/drug therapy; Hemophilia B/drug therapy; Hemorrhage/economics; Hemorrhage/prevention & control; Humans; Recombinant Proteins/economics; Recombinant Proteins/therapeutic use

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Quality of Life / Factor VIIa / Hemophilia B / Quality-Adjusted Life Years / Hemophilia A Type of study: Health_economic_evaluation / Prognostic_studies Aspects: Patient_preference Limits: Humans Language: En Journal: Haemophilia Journal subject: HEMATOLOGIA Year: 2010 Document type: Article Affiliation country: United States Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google